Click on image to view larger version.

Figure 2 Relationships between markers of oxidative stress and clinical status and cardiac performance in the complete population of patients conventionally treated (solid diamonds) and those treated with immunoglobulin adsorption (open diamonds). (A) Anti-oxidized low density lipoprotein autoantibodies (anti-oxLDL-AB) versus left ventricular ejection fraction (LVEF) prior to the study. (B) Thiobarbituric acid-reactive substances (TBARS) versus New York Heart Association functional class one year after immunoadsorption. (C) Lipid peroxides (LPO) versus LVEF one year after immunoadsorption. Prestudy to one-year change of anti-oxLDL-AB (d anti-oxLDL-AB) versus change of (D) LVEF (d LVEF), and (E) LVIDs (d LVIDs).